Role of chromium in human health and in diabetes

Diabetes Care

Volumn 27, Issue 11, 2004, Pages 2741-2751

  Cefalu, William T ^a   Hu, Frank B ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; ELEMENT; GLUCOSE; INSULIN; LIPID;

BODY COMPOSITION; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; DNA DAMAGE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; INSULIN METABOLISM; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LONG TERM CARE; NONHUMAN; REVIEW; SIDE EFFECT; TABLET;

CHROMIUM; DIABETES MELLITUS; HEALTH; HUMANS;

EID: 7444270286     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.11.2741     Document Type: Review

References (86)

1. Schwarz K, Mertz W: Chromium (III) and the glucose tolerance factor. Arch Biochem Biophys 85:292-295, 1959
2. Tuman RW, Doisy RJ: Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26:820-826, 1977
3. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parental nutrition. Am J Clin Nutr 30:531-538, 1977
4. Freund H, Atamian S, Fischer JE: Chromium deficiency during total parenteral nutrition. JAMA 241:496-498, 1979
5. Anderson RA: Chromium and parenteral nutrition. Nutrition 11:83-86, 1995
6. Kimura K: Role of essential trace elements in the disturbance of carbohydrate metabolism. Nippon Rinsho 54:79-84, 1996
7. Anderson RA: Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr 16:404-410, 1997
8. Chromium [Internet]. Available from http://www.nums.nwu.edu/nutrition/ factsheets/chromium.pdf. Accessed 17 September 2004
9. Chromium [Internet]. Available from http://vvww.nlm.nih.gov/medlineplus/ ency/article/002418.htm. Accessed 17 September 2004
10. Expert Group on Vitamins and Minerals: Review of chromium [Internet], 2002. Available from www.foodstandards.gov. uk/multimedia/pdfs/reviewofchrome. pdf. Accessed 3 February 2004
11. RDA recommendations [Internet]. Available from http://lifestyler.com/ lifestyler/ rdachart.htm. Accessed 29 January 2004
12. Anderson RA: Chromium, glucose intolerance and diabetes. J Am Coll Nutr 17:548-555, 1998
13. Anderson RA: Chromium as an essential nutrient: the chromium file [Internet]. Available from http://www.chromium-asoc.com/publications/ crfile6sep99.htm. Accessed 30 January 2004
14. PDRhealth: Chromium [Internet]. Available from http://www.pdrhealth.com/ drug_info/nmdrugprofiles/nutsupdrugs/ chr_0073.shtml. Accessed 3 February 2004
15. Vincent JB: Elucidating a biological role for chromium at a molecular level. Acc Chem Res 33:503-510, 2000
16. Hepburn DD, Vincent JB: Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J Inorg Biochem 94:86-93, 2003
17. Clodfelder BJ, Emamaullee J, Hepburn DD, Chakov NE, Nettles HS, Vincent JB: The trail of chromium (III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem 6:608-617, 2001
18. Vincent JB: The biochemistry of chromium. J Nutr 130:715-718, 2000
19. Vincent JB: Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J Am Coll Nutr 18:6-12, 1999
20. Davis CM, Sumrall KH, Vincent JB: A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35:12963-12969, 1996
21. Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, Elahi D: Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism 34:199-204, 1985
22. Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Showdhury S: Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem 13:690-697, 2002
23. Bahijri SM, Mufti AM: Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status. Biol Trace Elem Res 85:97-109, 2002
24. Anderson RA: Chromium as an essential nutrient for humans. Reg Toxicol Pharmacol 26:535-541, 1997
25. Roeback JR Jr, Hla KM, Chambless LE, Fletcher RH: Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers: a randomized, controlled trial. Ann Intern Med 115:917-924, 1991
26. Crawford V, Scheckenbach R, Preuss HG: Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diabetes Obes Metab 1:331-337, 1999
27. Campbell WW, Joseph LJ, Anderson RA, Davey SL, Hinton J, Evans WJ: Effects of resistive training and chromium picolinate on body composition and skeletal muscle size in older women. Int J Sport Nutr Exerc Metab 12:125-135, 2002
28. Lukaski HC, Bolonchuk WW, Siders WA, Milne DB: Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr 63:954-965, 1996
29. Hallmark MA, Reynolds TH, DeSouza CA, Dotson CO, Anderson RA, Rogers MA: Effects of chromium and resistive training on muscle strength and body composition. Med Sci Sports Exerc 28:139-144, 1996
30. Uusitupa MI, Mykkanen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Rassanen T, Kumpulainen J, Pyorala K: Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr 68:209-216, 1992
31. Wilson BE, Gondy A: Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Prac 28:179-184, 1995
32. Rabinowitz MB, Gonick HC, Levin SR, Davidson MB: Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6:319-327, 1983
33. Althuis MD, Jordan NE, Ludington EA, Wittes JT: Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 76:148-155, 2002
34. Pittler MH, Stevinson C, Ernst E: Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int J Obes Relat Metab Disord 27:522-529, 2003
35. Horlick L: Dyslipidemia and metabolic factors in the genesis of heart attack and stroke. Health Rep 6:94-99, 1994
36. Khamaisi M, Wexler ID, Skrha J, Strojek K, Raz I, Milicevic Z: Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities. Isr Med Assoc J 5:801-806, 2003
37. Rimm EB, Guallar E, Giovannucci E, Ascherio A, Stampfer MJ, Willet WC, Hu F: Toenail chromium levels and risk of coronary heart-disease among normal and overweight men. Presented at the American Heart Association 42nd Annual Conference on Cardiovascular Disease, Epidemiology and Prevention, 23-26 April 2002, Honolulu, Hawaii
38. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, Hu FB: Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 27:2211-2216, 2004
39. Vaquero MP: Magnesium and trace elements in the elderly: intake, status and recommendations. J Nutr Health Aging 6:147-153, 2002
40. Anderson RA: Chromium metabolism and its role in disease processes in man. Clin Physiol Biochem 4:31-41, 1986
41. Leeds AR: Glycemic index and heart disease. Am J Clin Nutr 76:2865-2895, 2002
42. Ding W, Chai Z, Duan P, Feng W, Qian Q: Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res 63:231-237, 1998
43. Davies S, McLaren Howard J, Hunnisett A, Howard M: Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients: implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46:469-473, 1997
44. Anderson RA, Kozlovsky AS: Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr 41:1177-1183, 1985
45. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46:1786-1791, 1997
46. Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA: Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol 13:57-61, 1999
47. Ekmekcioglu C, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl W: Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res 79:205-219, 2001
48. Zima T, Mestek O, Tesar V, Tesarova P, Nemecek K, Zak A, Zeman M: Chromium levels in patients with internal diseases. Biochem Mol Biol Int 46:365-374, 1998
49. American Diabetes Association: Nutrition principles and recommendations in diabetes (Position Statement). Diabetes Care 27 (Suppl. 1):S36-S46, 2004
50. Trow LG, Lewis J, Greenwood RH, Sampson MJ, Self KA, Crews HM, Fairweather-Tait SJ: Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes. Int J Vitam Nutr Res 70:14-18, 2000
51. Sherman L, Glennon JA, Brech WJ, Klomberg GH, Gordon ES: Failure of trivalent chromium to improve hyperglycemia in diabetes mellims. Metabolism 17:439-442, 1968
52. Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyorala KP, Koivistoinen PE, Lehto JT: Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 38:404-410, 1983
53. Mossop RT: Effects of chromium (III) on fasting glucose, cholesterol and cholesterol HDL levels in diabetics. Cent Afr J Med 29:80-82, 1983
54. Nath R, Minocha J, Lyall V, Sunder S, Kumar V, Kapoor S, Dhar KL: Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium 51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. In Chromium in Nutrition and Metabolism. Shapcott D, Hubert J, Eds. Amsterdam, Elsevier/ North Holland, 1979, p 213-222
55. Glinsman WH, Mertz W: Effect of trivalent chromium on glucose tolerance. Metabolism 15:510-520, 1966
56. Amato P, Morales AJ, Yen SS: Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci 55:M260-M263, 2000
57. Jovanovic L, Gutierrez M, Peterson CM: Chromium supplementation for women with gestational diabetes mellitus. J Trace Elem Exp Med 12:91-97, 1999
58. Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA: Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med 16:164-167, 1999
59. Morris BW, Kouta S, Robinson R, MacNeil S, Heller S: Chromium supplementation improves insulin resistance in patients with type 2 diabetes mellitus. Diabet Med 17:684-685, 2000
60. Cheng N, Zhu X, Shi H, Wu W, Chi J, Cheng J, Anderson R: Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. J Trace Elem Exp Med 12:55-60, 1999
61. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
62. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Wallon V, Shulman GI: Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867-872, 1998
63. Cefalu WT, Bell-Farrow AD, Wang ZQ, McBride D, Dalgleish D, Terry JG: Effect of glipizide GITS on insulin sensitivity, glycemic indices, and abdominal fat composition in NIDDM. Drug Dev Res 44:1-7, 1998
64. Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, Terry JG: Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 12:71-83, 1999
65. Morris BW, MacNeil S, Stanley K, Gray TA, Fraser R: The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J Endocrinol 139:339-345, 1993
66. Bahijri SM, Mira SA, Mufti AM, Ajabnoor MA: The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J 21:831-837, 2000
67. Chen SH, Sun YP, Chen XS: Effect of jiangtangkang on blood glucose, sensitivity of insulin and blood viscosity in non-insulin dependent diabetes mellitus [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 17:666-668, 1997
68. Ravina A, Slezak L, Rubal A, Mirsky N: Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elem Exp Med 8:183-190, 1995
69. Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41:768-771, 1992
70. Lee NA, Reasner CA: Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17:1449-1452, 1994
71. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
72. Kendall DM, Harmel AP: The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 8:S635-S653, 2002
73. Volpe SL, Huang HW, Larpadisorn K, Lesser II: Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr 20:293-306, 2001
74. Offenbacher EG, Pi-Sunyer FX: Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29:919-925, 1980
75. Sowers JR: Obesity as a cardiovascular risk factor. Am J Med 115:37S-41S, 2003
76. Kaats GR, Blum K, Fisher JA, Adelman JA: Effects of chromium picolinate supplementation on body composition: a randomized, double-masked placebo-controlled study. Cur Ther Res 57:747-756, 1996
77. Kaats GR, Blum K, Pullin D, Keith SC, Woods R: A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res 59:379-388, 1998
78. Evans GW: The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 11:163-180, 1989
79. Riales R, Albrink MJ: Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 34:2670-2678, 1981
80. Press RI, Geller J, Evans GW: The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 152:41-45, 1990
81. Preuss HG, Wallerstedt D, Talpur N: Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med 31:227-246, 2000
82. Guallar E: Toenail chromium status and cardiovascular disease risk in Europe. Presented at Chromium in Health and Disease, a CADRE Research Summit, 1-2 April 2003, Boston, Massachusetts
83. Wasser WG, Feldman NS, D'Agati VD: Chronic renal failure after ingestion of over-the-counter chromium picolinate (Letter). Ann Intern Med 126:410, 1997
84. Institute of Medicine (IOM): Chromium picolinate: prototype monograph. In Dietary Supplements: A Framework for Evaluating Safety. Washington, DC, Institute of Medicine, 2004, p. B1-B80
85. Berner TO, Murphy MM, Slesinski R: Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 42:1029-1042, 2004
86. Jeejeebhoy KN: The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 57:329-335, 1999